Mevion Receives 510(k) Clearance for HYPERSCAN Pencil Beam Scanning
Mevion Medical Systems has received FDA 510( k) clearance for the MEVION S250i Proton Treatment System including HYPERSCAN pencil beam of light scanning (PBS) innovation. HYPERSCAN PBS introduces unique energy layer changing and automated collimation systems. These advantages allow the S250i system to deliver much faster, sharper, and a lot more durable PBS proton radiation treatments.
" The S250i system represents the generation of intensity modulated proton therapy (IMPT) provided in the most small proton therapy platform," stated Joseph Jachinowski, Chief Executive Officer of Mevion Medical Solutions. "We are proud that the MEVION S250i system now has gotten both FDA clearance and CE mark. This is a very important turning point in our efforts to earn accuracy proton treatment readily available to much more people in the fight versus cancer cells."
Next Generation Intensity Modulated Proton Therapy (IMPT)
The MEVION S250i system is a compact proton treatment system capable of providing conformal radiation treatment treatments making use of HYPERSCAN pencil light beam scanning technology. The design of HYPERSCAN PBS technology conquers professional obstacles that were. formerly faced by initial generation PBS systems.
Pencil beam scanning systems shape the provided radiation dose by "paint" tumors spot-by-spot and layer-by- layer with sub-atomic particles. Before HYPERSCAN PBS, scanning proton systems dealt with distribution speed. Long distribution times could threaten the high accuracy of the treatment because of the target lump changing under normal body organ movement such as breathing.
HYPERSCAN PBS utilizes a portable light beam delivery path decreasing delivery times to less compared to 5 secs for some areas. This hyper-fast therapy shipment reduces therapy errors as a result of the level of sensitivity to motion that current PBS innovations face when treating tumors impacted by body organ motion.
In addition, HYPERSCAN PBS utilizes, the Flexible Aperture proton multi-leaf collimator (pMLC). This modern technology utilizes a robotically controlled collimation system, with the ability of cutting the sides of the beam at every layer of distribution. This capability supplies up to a 3 times sharper decline off in radiation at the shipment area edge. This enhances sparing of healthy cells and limits unneeded radiation to delicate places.
Worlds First HYPERSCAN PBS Installation
MedStar Georgetown University Hospital in Washington, D.C. will certainly be the first health center worldwide to provide this latest generation of HYPERSCAN PBS once final onsite testing is finished this month.
" We are delighted to be not only the very first and only proton therapy system in the Washington, D.C.area, however likewise the first worldwide to use these innovative proton therapy treatment capacities to our individuals and community. Currently, patients who seek proton treatment have to leave the municipal D.C. area, which could be a substantial problem on households," said Brian T. Collins, MD, clinical director of MedStar Georgetown Proton Treatment Facility. "We will currently be supplying sophisticated proton treatment, fully incorporated into our wide collection of extensive cancer treatment offerings. This is critical to the patients we serve.".
Built on Leading Compact Proton Therapy Technology
The MEVION S250i system is based upon Mevion's high efficiency, low financial risk S250 . Series platform. The core technology of the S250 Series is the world's only gantry installed superconducting synchrocyclotron. This compact, fully integrated platform has years of successful scientific experience and proven economic feasibility.
While proton therapy has clear dosimetric advantages, the prices of early systems has actually been a significant obstacle to adoption. The MEVION S250i decreases this obstacle with reduced capital prices, decreased operating costs, and increased therapy throughput. Mevion customers have actually achieved the fastest per-room person ramp-up in the history of proton treatment. Showing that compact proton therapy is a practical alternative for any type of size cancer facility is core to Mevion's goal of making proton therapy obtainable to as numerous clients as possible.
About Mevion Medical Systems
Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer cells individuals. Mevion is based in Littleton, Massachusetts, with a presence in the Europe, Japan and China. To learn more, please check out www.mevion.com.
Comply With Mevion on Twitter: https://twitter.com/mevionmedical.
Connect with Mevion on LinkedIn: https://www.linkedin.com/company/mevion-medical-.
systems.
LPR180103.
Sight source version on businesswire.com:.
http://www.businesswire.com/news/home/20180103005398/en/.
